A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol. (Q50321726)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 February 2018

Language	Label	Description	Also known as
English	A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.	scientific article published on 27 February 2018

Statements

scholarly article

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol. (English)

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

chemoradiotherapy

0 references

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yun Chen

1

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Zhengfei Zhu

2

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Weixin Zhao

3

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Ling Li

4

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Jinjun Ye

5

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Chaoyang Wu

6

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Huarong Tang

7

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Qin Lin

8

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Jiancheng Li

9

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Yi Xia

10

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Yunhai Li

11

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Jialiang Zhou

12

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Kuaile Zhao

13

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

publication date

27 February 2018

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Radiation Oncology

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

13

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

33

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

1

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

https://scigraph.springernature.com/pub.10.1186/s13014-018-0979-0

0 references

Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Combination of taxanes with radiation: preclinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Taxol: a novel radiation sensitizer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

22 May 2018

Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

14 August 2018

Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

14 August 2018

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

14 August 2018

Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

14 August 2018

Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5828310

30 November 2018

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiotherapy using taxanes for locally advanced esophageal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus]

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29482649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S13014-018-0979-0

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

1 reference

Europe PubMed Central

3 March 2018

http://europepmc.org/abstract/PMC/5828310

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50321726&oldid=1584653273"